Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 1999

View Archived Issues

CyDex and Allergan sign Captisol licensing agreement

Metabolic Modulators and Chugai sign drug discovery agreement

LeIF adjuvant enhances therapeutic efficacy of leishmaniasis vaccine in humans

LeukoSite: year-end 1998 highlights

DiagnoCure: Q1 1999 highlights

NeoPharm to collaborate with NCI on cytotoxic cancer ligand

Available for licensing from NIH: use of thymosin alpha1 for wound healing

Aronex initiates phase I/II trial of Atragen in bladder cancer

GVAX prostate cancer vaccine enters additional phase I/II trial

Select Therapeutics submits pre-IND in Canada for anticancer compound

U. Penn team synthesizes novel analogues of Ritalin for treatment of cocaine addiction

Versicor and Pharmacia & Upjohn join forces for development of new oxazolidinones

Phase III trial of Aliminase in ulcerative colitis initiated

Trega's analgesic effective in postoperative pain study

Novel anticonvulsants described by RCT

Neurokinin antagonists from Solvay particularly useful for GI disorders

Apoptosis-inducing peptide discovered at Morinaga Milk

Tularik presents novel compounds with dual antiproliferative and hypolipidemic effects

Peptidomimetic GH secretagogues synthesized under Japanese-U.S. collaboration

New class of potent, selective human glucagon receptor antagonists presented by Merck

Corvas reports design, synthesis and activity of selective peptidomimetic uPA inhibitors

RPR-CMV-423: a promising candidate for treatment of human CMV infection

Selective, orally active beta3-adrenoceptor agonists identified at Merck

Phase Ib trial of NBI-34060 successfully completed by Neurocrine Biosciences

Anti-CMV activity of BDCRB evaluated in newly designed preclinical model

Preclinical results indicate potential value of clevudine in chronic HBV infections

Didox outperforms hydroxyurea in murine AIDS model

Hughes Institute prepares novel NNRTIs useful as microbicidal spermicides

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...